Relationship between β-amyloid degradation and the 26S proteasome in neural cells

Experimental Neurology

Volumn 180, Issue 2, 2003, Pages 131-143

  Lopez Salon, M ^a   Pasquini, L ^a   Besio Moreno, M ^a   Pasquini, J M ^a   Soto, E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

26S proteasome; Alzheimer's disease; Lactacystin; Neurotoxicity; Ubiquitin; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; LACTACYSTIN; PROTEASOME;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONJUGATE; CONTROLLED STUDY; ENZYME ANALYSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

EID: 0037383052     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00060-2     Document Type: Article

References (66)

1. Adamo A.M., Pasquini L.A., Besio Moreno M., Oteiza P.I., Soto E.F., Pasquini J.M. Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system. J. Neurosci. Res. 55:1999;523-531.
2. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
3. Bradford M.M. Method of protein determination. Anal. Rev. Biochem. 72:1976;248-260.
4. Breweer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-Supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
5. Busciglio J., Lorenzo A., Yanker B.A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
6. Casaccia Bonnnefil P., Aibel L., Chao M.V. Central glia and neuronal population display differential sensitivity to ceramide dependent cell death. J. Neurosc. Res. 43:1996;382-389.
7. Ciechanover A., Schwartz A.L. The ubiquitin-proteasome pathway the complexity and myriad functions of proteins death. Proc. Natl. Acad. Sci. USA. 95:1998;2727-2730.
8. De Vrij F.M.S., Sluijs J.A., Gregori L., Fischer D.F., Hermens W.T.J.M.C., Golggaber D., Verhaagen J., Van Leeuwen F.W., Hol E.M. Mutant ubiquitin expressed in Alzheimer's disease cause neuronal death. Faseb J. 15:2001;2680-2688.
9. Ding Q., Keller J.N. Proteasome inhibition in oxidative stress neurotoxicity implications for heat shock proteins. J. Neurochem. 77:2001;1010-1017.
10. 2+ fluxes to inhibit apoptosis in thapsigargin- and glucocorticoid-treated mouse lymphoma cells. Cell Calcium. 19:1996;473-483.
11. Fenteany G., Schreiber S.L. Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273:1998;8545-8548.
12. Fergusson J., Landon M., Lowe J., Dawson S.P., Layfield R., Hanger D.P., Mayer R.J. Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci. Lett. 219:1996;167-170.
13. Glenner G.G., Murphy M.A. Amyloidosis of the nervous system. J. Neurol. Sci. 94:1989;1-28.
14. Glenner G.G., Wong C.W. Alzheimer's disease and Down's syndrome sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122:1984;1131-1135.
15. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
16. Gregori L., Bhasin R., Goldgaber D. Ubiquitin-mediated degradative pathway degrades the extracellular but not the intracellular form of amyloid β-protein precursor. Biochem. Biophys. Res. Commun. 203:1994;1731-1738.
17. Gregori L., Fuchs C., Figheiredo-Pereyra M.E., van Nostrand W.E., Goldgaber C. Amyloid betaprotein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270:1995;19702-19708.
18. Grundke-Iqbal I., Iqbal K., George L., Tung Y.C., Kim K.S., Wisniewski H.M. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl. Acad. Sci USA. 86:1989;2853-2857.
19. Guiroy D.C., Miuazaki M., Multhaup G., Fischer P., Garruto R.M., Beyreuther K., Masters C.L., Simms G., Gibbs C.J., Gajdusek D.C. Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence. Proc. Natl. Acad. Sci. USA. 84:1987;2073-2077.
20. Haas C., Schlossmacher M., Hung A., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberbug Y., Koo E., Schenk D., Teplow D., Selkoe D. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
21. Hardy J., Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 282:1998;1075-1079.
22. Hershko A., Ciechanover A. The ubiquitin pathway for the degradation of intracellular proteins. Prog. Nucleic Acids Res. Mol. Biol. 33:1986;19-56.
23. Hertz L., Jurlink B.H.J., Fosmark H., Schousboe A. Astrocytes in primary cultures. Pfeiffer S.E. Neuroscience Approached through Cell Culture. 1982;175-186 CRC Press, Boca Raton, FL.
24. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Riedel N.G., Sahasrabudhe S. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA. 95:1998;3275-3280.
25. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
26. Itagaki S., Mc Geer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:1989;173-182.
27. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals evidence that an initially deposited species is Aβ 42(43). Neuron. 13:1994;45-53.
28. Jarret J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
29. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer disease. J. Neurochem. 75:2000;436-439.
30. 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J Biol. Chem. 277:2002;15666-15670.
31. Klein W.L., Krafft G.A., Finch C.E. Targeting small Aβ oligomers the solution to an Alzheimer's disease conundrum? Trends. Neurosci. 24:2001;219-224.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Lam Y.A., Pickart C.M., Alban A., Landon M., Jamieson C., Ramage R., Mayer R.J., Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;9902-9906.
34. Le Blanc A.C., Xue R., Gambett P. Amyloid precursor protein metabolism in primary cultures of neurons, astrocytes and microglia. J. Neurochem. 66:1996;2300-2310.
35. Lopez Salon M., Morelli L., Castaño E.M., Soto E.F., Pasquini J.M. Defective ubiquitinization of cerebral proteins in Alzheimer disease. J. Neurosci. Res. 62:2000;302-310.
36. Lowe J., McDermott H., Landon M., Mayer R.J., Wilkinson K.D. Ubiquitin carboxyl-terminal hydrolase (PSP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161:1990;153-160.
37. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radicals Biol. Med. 23:1997;134-147.
38. Masters C.L., Multhaup G., Simms G., Pottgiesser J., Martins R.N., Beyreuther K. Neuronal origin of a cerebral amyloid neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid plaque cores and blood vessels. EMBO J. 4:1985;2757-2763.
39. McCarthy K.D., De Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissues. J. Cell. Biol. 85:1980;890-902.
40. Mentlein R., Ludwig R., Martensen I. Proteolytic degradation of Alzheimer's disease amyloid beta-peptide by a metalloproteinase from microglia cells. J. Neurochem. 70:1998;721-726.
41. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K., Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron. 10:1993;1151-1160.
42. Naidu A., Quon D., Cordell B. β-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J. Biol. Chem. 270:1995;1369-1374.
43. 2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911.
44. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
45. Pasquini L.A., Besio Moreno M., Adamo A.M., Pasquini J.M., Soto E.F. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cells. J. Neurosci. Res. 59:2000;601-611.
46. Perez A., Morelli L., Cresto J.C., Castaño E.M. Degradation of soluble amyloid β peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem. Res. 25:2000;247-255.
47. Perry G., Mulvihill P., Fried V.A., Smith H.T., Grundke-Iqbal, I., Iqbal K. Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease. J. Neurochem. 52:1989;1523-1528.
48. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro the roles of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
49. Pike C.J., Cummings B.J., Cotman C.W. β-Amyloid induces neuritic dystrophy in vitro similarities with Alzheimer pathology. NeuroReport. 3:1992;769-772.
50. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
51. Pike C.J., Walencewickz-Wasserman A.J., Komoski J., Cribbs D.A., Glabe C.G., Cotman C.W. Structure-activity analyses of β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
52. Qiu J.H., Asai A., Chi S., Saito N., Hamada H., Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3 like protease mediated apoptosis in cultured cortical neurons. J. Neurosci. 20:2000;259-265.
53. Qiu W.Q., Ye Z., Hholodenko D., Seubert P., Selkoe D.J. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 272:1997;6641-6646.
54. Rechsteiner, M., 1998. Ubiquitin and the biology of the cell, in: Peters et al. (Eds.), The 26S Proteasome, Plenium, New York, pp. 147-189.
55. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffner L.M., Cai X.D., McKay D.M., Tinttner R., Younkin S.G. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 258:1992;126-129.
56. Smith M.A., Nunomura A., Zhu X., Takeda A., Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid. Redox Signal Fall. 2:2000;413-420.
57. Spillantini M.G., Goedert M., Jakes R., Klug A. Topographical relationship between β-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. Proc. Natl. Acad. USA. 87:1990;3952-3956.
58. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA. 95:1998;7737-7741.
59. Taddei N., Liguri G., Sorbi S., Amaducci L., Camici G., Nassi P., Cecchi C., Ramponi G. Cerebral soluble ubiquitin is increased in patients with Alzheimer's disease. Neurosci. Lett. 151:1993;158-161.
60. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St. George Hyslop P.H., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., Neve R.L. Amyloid beta protein gene cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
61. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubaber A., Sonnemans M.A., Slujis A., Koycu S., Ramdjeielal R.D.J., Salehi A., Martens G.J.M., Grosveld F.G., Peter J., Burbach H., Hol E.M. Frameshift mutants of beta amyloid precursor protein and ubiquitin B in Alzheimer's disease and down patients. Science. 279:1998;242-247.
62. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., Rosner M.R., Selkoe D.J. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin degrading enzyme. J. Neurosci. 20:2000;1657-1665.
63. Wang G.P., Khatoon S., Iqbal K., Grundke-Iqbal I. Brain ubiquitin is markedly elevated in Alzheimer's disease. Brain Res. 566:1991;146-151.
64. Wiesner D.A., Dawson G. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66:1996;1418-1425.
65. Yankner B.A., Dawes L.R., Fischer S., Villa-Komaroff L., Oster-Granite M.L., Berve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
66. Zhang Y., McLaughlin R., Goodyer C., LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide 1-42 through p53 and Bax in cultured primary human neurons. J. Cell. Biol. 156:2002;519-529.